Implementation and evaluation of group psychotherapeutic interventions in patients with chronic pain - a controlled clinical trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00037260

Enrollment

Registered

2025-07-01

Start date

2025-04-04

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F45.41

Interventions

Group 1: The participants receive manualized group psychotherapy consisting of eight sessions. In addition, there is a ninth session for the patients relatives. Group 2: The participants receive manua

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Written consent to participate in the study - Fluency in German

Exclusion criteria

Exclusion criteria: - Severe psychiatric illnesses according to ICD-10 (psychoses, addictions, bipolar disorders or severe cases of chronic pain) - Suicidal thoughts - Lack of capacity to consent

Design outcomes

Primary

Measure	Time frame
How effective is group psychotherapy in reducing pain and improving quality of life? The primary endpoint is the evaluation of the effectiveness of the therapy based on pain reduction and improved quality of life in everyday life. This is tested using questionnaires that are collected at three measurement points (before the start of group therapy, after completion of the therapeutic units and catamnestically three months after the end of treatment). The following questionnaires including sociodemographics with previous illnesses are used: - MGP (Short) - WHO-5 - GAD-7 - PHQ-9 - CTQ - PSQ-20 - SSD-12 - FSS - SWE - RS-13 - TFA - PSEQ - CPAQ - HAQ-DI - Quality of life (SF-12) - ZUF-8 - INEP	—

Measure

Time frame

How effective is group psychotherapy in reducing pain and improving quality of life? The primary endpoint is the evaluation of the effectiveness of the therapy based on pain reduction and improved quality of life in everyday life. This is tested using questionnaires that are collected at three measurement points (before the start of group therapy, after completion of the therapeutic units and catamnestically three months after the end of treatment). The following questionnaires including sociodemographics with previous illnesses are used: - MGP (Short) - WHO-5 - GAD-7 - PHQ-9 - CTQ - PSQ-20 - SSD-12 - FSS - SWE - RS-13 - TFA - PSEQ - CPAQ - HAQ-DI - Quality of life (SF-12) - ZUF-8 - INEP

—

Secondary

Measure	Time frame
How is the intervention perceived by patients and therapists? Which processes influence the effectiveness of group psychotherapy? What barriers and support factors exist during implementation? Is there a greater reduction in pain among patients with the additional body therapy sessions? Additionally to the above-mentioned questionnaires for patients with the 4 body-oriented units we will be using (at three measurement points: before the start of therapy, after completion of the therapeutic units and catamnestically three months after the end of treatment): - MAIA-2 - TampaScale of kinesiophobia - Body Appreciation Scale 2 - Fear-Avoidance Beliefs Questionnaire - FFMQ-39	—

Measure

Time frame

How is the intervention perceived by patients and therapists? Which processes influence the effectiveness of group psychotherapy? What barriers and support factors exist during implementation? Is there a greater reduction in pain among patients with the additional body therapy sessions? Additionally to the above-mentioned questionnaires for patients with the 4 body-oriented units we will be using (at three measurement points: before the start of therapy, after completion of the therapeutic units and catamnestically three months after the end of treatment): - MAIA-2 - TampaScale of kinesiophobia - Body Appreciation Scale 2 - Fear-Avoidance Beliefs Questionnaire - FFMQ-39

—

Countries

Germany

Contacts

Public ContactCaroline Rometsch

Universitätsklinikum Magdeburg, Klinik für Psychosomatische Medizin und Psychotherapiue

caroline.rometsch@med.ovgu.de0391 67 25711

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026